FAKTOR OPTIONSSCHEIN - AMGEN | Market Closed - Boerse Frankfurt Warrants 01:26:51 2024-05-24 pm EDT | ||
| 3.78 EUR | +3.28% |
|
| Current month | -51.10% | ||
| 1 month | -51.85% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
AMGEN INC.
Latest news about AMGEN INC.
| Date | Price | Change |
|---|---|---|
| 24-05-24 | 3.78 | +3.28% |
| 24-05-23 | 3.66 | +4.27% |
| 24-05-22 | 3.51 | 0.00% |
| 24-05-21 | 3.51 | +1.45% |
| 24-05-20 | 3.46 | -0.29% |
Real-time Boerse Frankfurt Warrants
Last update May 24, 2024 at 01:26 pm EDT
More quotesStatic data
| Product type | Exotic Products |
|---|---|
| Buy / Sell | CALL |
| Underlying | AMGEN INC. |
| Issuer | UBS |
| WKN | UM2P5C |
| ISIN | DE000UM2P5C3 |
| Date issued | 2024-02-01 |
| Strike | 383.1 $ |
| Maturity | Unlimited |
| Parity | 18.16 : 1 |
| Emission price | 5.14 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 9.51 € |
|---|---|
| Lowest since issue | 2.94 € |
| Spread | 0.15 € |
| Spread % | 3.75% |
Company Profile
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows:
- drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.;
- other (5.8%): primarily royalties.
The United States account for 70.3% of net sales.
Sector
-
Consensus: Amgen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
305.8
USD
Average target price
316.3
USD
Spread / Average Target
+3.41%
- Stock Market
- Certificates
- Certificat
